Adrian Bloor

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

John C. Byrd, Jennifer R. Brown, Susan O’Brien et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study

Adrian Bloor, Amit Patel, James E. Griffin et al. · Nature Medicine · 2020 · 280 citations · Full text

Regenerative Medicine, Dose-escalation Study, Translational Medicine +11

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study

Peter Hillmen, Andy C. Rawstron, Kristian Brock et al. · Journal of Clinical Oncology · 2019 · 264 citations · Full text

Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma

Kirsty Thomson, Emma Morris, Adrian Bloor et al. · Journal of Clinical Oncology · 2008 · 166 citations · Full text

Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of <i>TP53</i>: Final Results of the National Cancer Research Institute CLL206 Trial

Andrew R. Pettitt, Richard E. Jackson, Stacey Carruthers et al. · Journal of Clinical Oncology · 2012 · 164 citations